Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/IMA/Capital expenditures

ImageneBio, Inc. (IMA) Capital expenditures 2021–2024

ImageneBio, Inc. (IMA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$414,000FY2024 · since FY2021: $766,000 → $414,000
21222324
Fiscal yearValueYoY
FY2024$414,000-71.1%
FY2023$1.4M-18.7%
FY2022$1.8M+129.8%
FY2021$766,000—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More IMA financial trends

IMA RevenueIMA Net incomeIMA Net marginIMA Gross profitIMA Gross marginIMA Operating incomeIMA Operating marginIMA Operating cash flowIMA Free cash flowIMA Return on equityIMA Stock buybacksIMA Dividends paidIMA Total assetsIMA Total liabilitiesIMA Shareholders’ equityIMA overview →